Trials / Recruiting
RecruitingNCT06622941
Study to ONO-4538 in Patients With Rhabdoid Tumor
A Multicenter, Open-label, Uncontrolled Phase II Study to Investigate Efficacy and Safety of ONO4538 in Patients With Rhabdoid Tumor
- Status
- Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 23 (estimated)
- Sponsor
- Ono Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 1 Year
- Healthy volunteers
- Not accepted
Summary
Investigate the efficacy and safety of ONO-4538 for the treatment of rhabdoid Tumors
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ONO-4538 | every 2 weeks |
Timeline
- Start date
- 2024-11-25
- Primary completion
- 2029-01-31
- Completion
- 2030-03-31
- First posted
- 2024-10-02
- Last updated
- 2026-03-12
Locations
5 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT06622941. Inclusion in this directory is not an endorsement.